Europe - Pharmaceutical Executive



Industry/Gov't R&D Support: So Far So Good

February 1, 2012

The EU's Innovative Medicines Initiative is helping to invigorate new drug development, but there are still many hurdles to tackle before its promise is realized.

Here's to a Happier New Year?

January 1, 2012

A turbulent year is ahead for European pharma, while EFPIA's Director General begins to rethink its approach to new science.

Does a German Launch Make Sense?

November 1, 2011

Will the structure and ambiguity of Germany's new medicines pricing system bring a halt to new drug launches in Europe's largest market?

Europe Tackles 'Advertising in Disguise' Fears

November 1, 2011

The EC's latest proposals have thrown water on Europe's firey Direct-to-Consumer advertising debate. But is it enough to keep the flames at bay?

Strategic Acquisition: A CEO's View

October 31, 2011

Richard Pops, Chief Executive Officer of Alkermes, explains how the company has established itself as a global, Irish-based firm.

Sweden: Setting the Pace for Global Pharma

October 1, 2011

Garbo gets it ...

Sir Michael Rawlins: Regulation and Reputation

October 1, 2011

Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence

Innovating Around Innovation

September 1, 2011

Richard Barker, former Director General of ABPI, proposes a new agenda on how to restore public confidence in the value behind science.

Europe in HTA Gridlock

August 1, 2011

HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.


Click here